Japan, Jan. 23 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR MAKING ANTIBODIES BASED ON USE OF EXPRESSION-ENHANCING LOCUS.' Other related details are as follows:
Application Number: JP,2024-144352
Category (FI): C12N15/13,C12N15/85@Z,C12N5/10,C12P21/08,C07K16/46
Stage: Grant (IP right document published.)
Filing Date: Aug. 26, 2024
Publication Date: Nov. 26, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
